DOSAGE FORM CONTAINING A STATIN

摘要

The present invention relates to a novel stable pharmaceutical dosage form containing an HMG-CoA reductase inhibitor and free of stabilizing agents, said dosage form comprising an HMG-CoA reductase inhibitor combined with at least the followi ng pharmaceutically acceptable excipients: colloidal silicon dioxide, microcrystalline cellulose, and lactose monohydrate and processes to make such.